Prostate Drug Earns Invention Award
WASHINGTON (AP) _ Researchers who developed a new drug to treat enlarged prostates were named inventors of the year on Thursday.
Two other teams of researchers also were honored for their work developing an improved tire and a faster method for producing synthetic chemicals.
″It’s not just the contribution from one individual but the assembly of individuals ... that makes things happen,″ said Stephen P. A. Fodor, named one of the year’s distinguished inventors.
″The development of new technology is a hallmark of this country and we need to preserve that attitude,″ said Fodor of Affymax Research Institute in Palo Alto, Calif.
Intellectual Property Owners Inc. presented Inventor of the Year and two Distinguished Inventor awards. This is the 20th year the awards have been issued by the nonprofit association representing holders of patents, copyrights and trademarks.
Inventor of the Year went to Gary H. Rasmusson and Glenn F. Reynolds of Merck & Co., in Rahway, N.J., developers of Proscar, used to treat benign prostate disease, a malady that affects many men. Previously the condition was treated with surgery. The Food and Drug Administration approved the drug last year.
Distinguished Inventor awards went to:
- Fodor, Michael C. Pirrung, J. Leighton Read and Lubert Stryer of Affymax Research Institute in Palo Alto, Calif., who developed a system for speeding the process of making synthetic chemicals.
- John S. Attinello, Jean Bergh, Fernand A. J. Fourgon, William E. Glover, Adel F. Halasa, Samuel P. Landers and Paul B. Maxwell of Goodyear Tire & Rubber Co. for developing the Aquatred tire, which gives extra traction on wet roads.